Tenofovir DF

Fidelia Bernice, Pharm.D., BCIDP
Pediatric Dosing Author: Bethany Sharpless Chalk, Pharm.D., BCPPS
Tenofovir DF is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please or .

Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:

-- The first section of this topic is shown below --

INDICATIONS

FDA

  1. Treatment of HIV-infection in adults and pediatric patients (≥2 years of age, weighing ≥10 kg) in combination with other antiretroviral drugs.
  2. Treatment of HBV in adults and pediatric patients ≥2 years of age, weighing ≥10 kg

NON-FDA APPROVED USES

  • Treatment of hepatitis in HIV-HBV co-infected pts.

-- To view the remaining sections of this topic, please or --

INDICATIONS

FDA

  1. Treatment of HIV-infection in adults and pediatric patients (≥2 years of age, weighing ≥10 kg) in combination with other antiretroviral drugs.
  2. Treatment of HBV in adults and pediatric patients ≥2 years of age, weighing ≥10 kg

NON-FDA APPROVED USES

  • Treatment of hepatitis in HIV-HBV co-infected pts.

There's more to see -- the rest of this entry is available only to subscribers.

Last updated: January 14, 2021